Lassa virus is a key pathogen that can cause haemorrhagic fever and further understanding of successful therapeutic strategies are needed. Here the authors explore the use of a Lassa virus glycoprotein-based vaccine and show B cell immunity as a correlate of protection in a mouse model of vaccination and subsequent viral challenge
- Tiago Abreu-Mota
- Anna-Friederike Marx
- Daniel D. Pinschewer